NHS
Number of GPs in decline for first time in 50 years
May 8, 2019Manufacturing and Production, Research and Development GP, NHS, pharma, public health
The number of GPs has been in decline, year on year, since 2014. The decline marks the first sustained fall …
Will mobile phones save the NHS?
May 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, feature, mhealth, mobile health, pharma
The NHS is sick. According to politicians and NHS chiefs, the cure involves a strong dose of mHealth. Louis Goss …
Two thirds of MPs believe NHS should spend less on medicines
April 30, 2019Manufacturing and Production Long Term Plan, MPs, NHS, UK, government, health, public health
Nearly two thirds (64%) of MPs believe the NHS should direct more resources towards prevention, over funding for new treatments, …
The price of access: Can the NHS afford Orkambi?
April 29, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, NHS, NICE, Orkambi, UK, Vertex, access, cystic fibrosis, feature, pharma, pricing
The impasse over access to Vertex’s Orkambi for cystic fibrosis patients in England and Wales has revealed the cracks in …
NICE recommends Akcea’s Tegsedi for rare, life-threatening progressive disease
April 17, 2019Research and Development, Sales and Marketing Akcea, NHS, NICE, Tegsedi, UK
Akcea Therapeutics has shared the news that Tegsedi (inotersen), its antisense oligonucleotide (ASO) inhibitor of human transthyretin (TTR) production, has …
Half of patients have sub-optimal response to statins, research shows
April 16, 2019Manufacturing and Production NHS, NICE, NICE guidelines, cholesterol, health, statins
Around half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, …
Novartis’ Kisqali combo rejected by NICE for advanced breast cancer
April 11, 2019Sales and Marketing Kisqali, NHS, NICE, Novartis, pharma
Novartis’ Kisqali (ribociclib) has been rejected for use on the NHS by NICE for the treatment of advanced breast cancer, …
Eisai and MSD’s Lenvima recommended for NHS Scotland in advanced or unresectable liver cancer
April 8, 2019Manufacturing and Production, Sales and Marketing Cancer, NHS, Scotland, Scottish Medicines Consortium, UK, liver cancer, pharma
Patients in Scotland with with advanced or unresectable hepatocellular carcinoma (HCC) will now be able to access Eisai and MSD’s …
NICE turns down Astellas’ Xtandi in prostate cancer
April 8, 2019Research and Development, Sales and Marketing Astellas, Cancer, NHS, NICE, UK, pharma, prostate cancer
Astellas’ Xtandi (enzalutamide) has been rejected by UK medicines watchdog NICE for use on the NHS as a therapy for …
NHS England threatened legal action against Oxford University hospitals trust
April 4, 2019Medical Communications, Research and Development Hopsitals, NHS, NHS England, OUH, cancer screening, patients
NHS England threatened to sue Oxford University hospitals (OUH) NHS trust after they objected to the former’s controversial decision to …
NHS gender pay gap has increased since last year
April 3, 2019Research and Development NHS, NHS trusts, analysis, gender pay gap, salary
The gender pay gap has worsened in the NHS, according to analysis from The Guardian, which found the gender pay …
AstraZeneca’s Imfinzi to be made available via Cancer Drugs Fund in England
March 28, 2019Sales and Marketing AstraZeneca, Cancer, Imfinzi, NHS, NICE, UK, lung cancer
AstraZeneca’s PD-L1 inhibitor Imfinzi (durvalumab) will now be made available to English lung cancer patients on the NHS via the …
Shortage of cancer doctors puts NHS patients at risk
March 19, 2019Manufacturing and Production, Research and Development Cancer, NHS, oncologists, radiology, shortfall, staff
A shortage of cancer doctors is putting patients at risk, according to a new report from the Royal College of …
NHS struggles to meet targets as more demand for services grows
March 18, 2019Sales and Marketing A&E, NHS, hospitals
The NHS is struggling to meet targets as the health service is being used by more patients than ever before, …
